Abstract

In many cases of trauma, the same environmental stimuli that become associated with aversive events are experienced on other occasions without adverse consequence. We examined neural circuits underlying partially reinforced fear (PRF), whereby mice received tone-shock pairings on half of conditioning trials. Tone-elicited freezing was lower after PRF conditioning than fully reinforced fear (FRF) conditioning, despite an equivalent number of tone-shock pairings. PRF preferentially activated medial prefrontal cortex (mPFC) and bed nucleus of the stria terminalis (BNST). Chemogenetic inhibition of BNST-projecting mPFC neurons increased PRF, not FRF, freezing. Multiplexing chemogenetics with in vivo neuronal recordings showed elevated infralimbic cortex (IL) neuronal activity during CS-onset and freezing-cessation; these neural correlates were abolished by chemogenetic mPFC®BNST inhibition. These data suggest mPFC®BNST neurons limit fear to threats with a history of partial association with an aversive stimulus, with potential implications for understanding the neural basis of trauma-related disorders.

Data availability

Some of the data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figure 1.

Article and author information

Author details

  1. Lucas R Glover

    LBGN, NIH, Rockville, United States
    For correspondence
    lucasglover@email.gwu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1127-3819
  2. Kerry M McFadden

    LBGN, NIH, Rockville, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Max Bjorni

    Department of Psychology, Santa Clara University, Santa Clara, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Sawyer R Smith

    LBGN, NIH, Rockville, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Natalie G Rovero

    Department of Psychology, Santa Clara University, Santa Clara, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Sarvar Oreizi-Esfahani

    LBGN, NIH, Rockville, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Takayuki Yoshida

    LBGN, NIH, Rockville, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Abagail F Postle

    LBGN, NIH, Rockville, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Mio Nonaka

    LBGN, NIH, Rockville, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Lindsay R Halladay

    Department of Psychology, Santa Clara University, Santa Clara, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Andrew Holmes

    LBGN, NIH, Rockville, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7308-1129

Funding

National Institute on Alcohol Abuse and Alcoholism (NIAAA-IRP)

  • Andrew Holmes

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experimental procedures were approved by the NIAAA (protocol # LBGN-AH-01) and Santa Clara University (SCU AWA: D18-01042) Animal Care and Use Committees and followed the NIH guidelines outlined in 'Using Animals in Intramural Research' and the local Animal Care and Use Committees.

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 3,329
    views
  • 456
    downloads
  • 26
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Lucas R Glover
  2. Kerry M McFadden
  3. Max Bjorni
  4. Sawyer R Smith
  5. Natalie G Rovero
  6. Sarvar Oreizi-Esfahani
  7. Takayuki Yoshida
  8. Abagail F Postle
  9. Mio Nonaka
  10. Lindsay R Halladay
  11. Andrew Holmes
(2020)
A prefrontal-bed nucleus of the stria terminalis circuit limits fear to uncertain threat
eLife 9:e60812.
https://doi.org/10.7554/eLife.60812

Share this article

https://doi.org/10.7554/eLife.60812

Further reading

    1. Immunology and Inflammation
    2. Neuroscience
    Rocio Vicario, Stamatina Fragkogianni ... Frédéric Geissmann
    Research Article

    Somatic genetic heterogeneity resulting from post-zygotic DNA mutations is widespread in human tissues and can cause diseases, however, few studies have investigated its role in neurodegenerative processes such as Alzheimer’s disease (AD). Here, we report the selective enrichment of microglia clones carrying pathogenic variants, that are not present in neuronal, glia/stromal cells, or blood, from patients with AD in comparison to age-matched controls. Notably, microglia-specific AD-associated variants preferentially target the MAPK pathway, including recurrent CBL ring-domain mutations. These variants activate ERK and drive a microglia transcriptional program characterized by a strong neuro-inflammatory response, both in vitro and in patients. Although the natural history of AD-associated microglial clones is difficult to establish in humans, microglial expression of a MAPK pathway activating variant was previously shown to cause neurodegeneration in mice, suggesting that AD-associated neuroinflammatory microglial clones may contribute to the neurodegenerative process in patients.

    1. Neuroscience
    Jean-François Brunet
    Review Article

    Historically, the creation of the parasympathetic division of the autonomic nervous system of the vertebrates is inextricably linked to the unification of the cranial and sacral autonomic outflows. There is an intriguing disproportion between the entrenchment of the notion of a ‘cranio-sacral’ pathway, which informs every textbook schematic of the autonomic nervous system since the early XXth century, and the wobbliness of its two roots: an anatomical detail overinterpreted by Walter Holbrook Gaskell (the ‘gap’ between the lumbar and sacral outflows), on which John Newport Langley grafted a piece of physiology (a supposed antagonism of these two outflows on external genitals), repeatedly questioned since, to little avail. I retrace the birth of a flawed scientific concept (the cranio-sacral outflow) and the way in which it ossified instead of dissipated. Then, I suggest that the critique of the ‘cranio-sacral outflow’ invites, in turn, a radical deconstruction of the very notion of a ‘parasympathetic’ outflow, and a more realistic description of the autonomic nervous system.